Drug Trial Radar · NCT04174716
Basket Trial of IDX-1197, a PARP Inhibitor, in Patients With HRR Mutated Solid Tumors (VASTUS)
Last checked: Nov 19, 2026Latest source record: Apr 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
108
Actual
Start
Nov 6, 2019
Primary completion
Mar 31, 2023
Study completion Jun 28, 2024
Sponsor
- Lead sponsor
- Idience Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Nov 22, 2019
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 19 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a Phase 1b/2a basket trial to assess safety and efficacy of IDX-1197 in patients with HRR mutation. There are two parts to this study: Phase 1b, IDX-1197 dose-selection study to determine RP2D and Phase 2a, non-randomized parallel dose expansion study to confirm RP2D.
Conditions
- Solid Tumors
- Homologous Recombination Repair Gene Mutation
- Homologous Recombination Deficiency
Interventions
IDX-1197Drug
Until progression or unacceptable toxicity develops
Primary outcomes
What the sponsor says the trial is designed to measure.
- objective response rate (ORR)Time frame: Up to 24 weeks
Locations
19 sites in 1 country. Site status is shown where the registry gives one.
Inje University Haeundae Hospital
Busan, South Korea
Dong-a University Hospital
Busan, South Korea
Pusan National University Yangsan Hospital
Busan, South Korea
Gachon University Gil Medical Center
Incheon, South Korea
Cha University Bundang Medical Center
Seongnam-si, South Korea
Korea University Anam Hospital
Seoul, South Korea
Seoul National University Hospital
Seoul, South Korea
Kangbuk Samsung Hospital
Seoul, South Korea
Severance Hospital, Yonsei University Health System
Seoul, South Korea
Asan Medical Center
Seoul, South Korea
Samsung Medical Center
Seoul, South Korea
The Catholic University of Korea, Seoul St. Mary's Hospital
Seoul, South Korea
Seoul Metropolitan Government Seoul National University Boramae Medical Center
Seoul, South Korea
Korea University Guro Hospital
Seoul, South Korea
National Cancer Centre
Goyang, Gyeongggi-do, South Korea
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea
Ajou University Hospital
Suwon, Gyeonggi-do, South Korea
Gyeongsang National University Hospital
Jinju, Gyeongsangnam-do, South Korea
Chonnam National University Hwasun Hospital
Hwasun, Jeollanam-do, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.